- Home
- / Sol-Gel Technologies
Sol-Gel Technologies
Stock Price
$0.6
2024-10-29
Market Capitalization
$18 M
2024-10-29
Revenue
$19.4 M
FY, 2025
Sol-Gel Technologies Summary
Company Summary
- Overview
- Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. The Company designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
- Type
- Public
- Status
- Active
- Founded
- 1997
- HQ
- Ness Ziona, IL | view all locations
- Website
- http://www.sol-gel.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Gilad Mamlok, CFO
Ofer Toledano, VP Research and Development
Ofra Levy-Hacham, VP Clinical and Regulatory Affairs
LocationsView all
1 location detected
Ness Ziona, Center District HQ
Israel
7 Golda Me'ir St
Sol-Gel Technologies Financials
Summary Financials
- Revenue (FY, 2025)
- $19.4M
- Gross profit (FY, 2025)
- $19.4M
- Net income (FY, 2025)
- ($6.1M)
- Cash (FY, 2025)
- $11.0M
- EBIT (FY, 2025)
- ($7.5M)